PureTech Health (PRTC) Invested Capital (2019 - 2023)
PureTech Health (PRTC) has disclosed Invested Capital for 5 consecutive years, with $464.1 million as the latest value for Q4 2023.
- Quarterly Invested Capital fell 16.78% to $464.1 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $464.1 million through Dec 2023, down 16.78% year-over-year, with the annual reading at $464.1 million for FY2023, 16.78% down from the prior year.
- Invested Capital for Q4 2023 was $464.1 million at PureTech Health, down from $557.6 million in the prior quarter.
- The five-year high for Invested Capital was $684.6 million in Q4 2020, with the low at $464.1 million in Q4 2023.
- Average Invested Capital over 5 years is $596.6 million, with a median of $608.6 million recorded in 2021.
- The sharpest move saw Invested Capital rose 2.47% in 2020, then dropped 16.78% in 2023.
- Over 5 years, Invested Capital stood at $668.0 million in 2019, then increased by 2.47% to $684.6 million in 2020, then decreased by 11.09% to $608.6 million in 2021, then fell by 8.38% to $557.6 million in 2022, then fell by 16.78% to $464.1 million in 2023.
- According to Business Quant data, Invested Capital over the past three periods came in at $464.1 million, $557.6 million, and $608.6 million for Q4 2023, Q4 2022, and Q4 2021 respectively.